Oral antiviral therapies for chronic hepatitis C infection
about
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North AfricaBystander hyperactivation of preimmune CD8+ T cells in chronic HCV patientsOver-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a.Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanismDrug interactions between buprenorphine, methadone and hepatitis C therapeutics.
P2860
Oral antiviral therapies for chronic hepatitis C infection
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Oral antiviral therapies for chronic hepatitis C infection
@ast
Oral antiviral therapies for chronic hepatitis C infection
@en
Oral antiviral therapies for chronic hepatitis C infection
@nl
type
label
Oral antiviral therapies for chronic hepatitis C infection
@ast
Oral antiviral therapies for chronic hepatitis C infection
@en
Oral antiviral therapies for chronic hepatitis C infection
@nl
prefLabel
Oral antiviral therapies for chronic hepatitis C infection
@ast
Oral antiviral therapies for chronic hepatitis C infection
@en
Oral antiviral therapies for chronic hepatitis C infection
@nl
P2093
P2860
P356
P1476
Oral antiviral therapies for chronic hepatitis C infection
@en
P2093
P2860
P304
P356
10.1177/2049936113488359
P407
P577
2013-06-01T00:00:00Z